Sanjiv Narayan: Why Machine Learning Matters in Treating Complex Arrhythmias

Lynn Martelli
Lynn Martelli

Dr. Sanjiv Narayan is a Stanford University professor and leading figure in cardiac electrophysiology with over two decades of experience in the medical field. Sanjiv Narayan has contributed extensively to the understanding and treatment of arrhythmias, including the co-development of focal impulse and rotor modulation therapy and advancements in atrial fibrillation care. Educated at the University of Birmingham, with further research and academic roles at institutions such as UCLA, Harvard Medical School, and MIT, his work bridges clinical medicine, neuroscience, and data-driven innovation. His involvement with organizations like the American Heart Association and the Heart Rhythm Society reflects a sustained commitment to improving cardiovascular outcomes, including the integration of emerging technologies such as machine learning into arrhythmia treatment.

Why Machine Learning Matters in Treating Complex Arrhythmias

Machine learning (a form of artificial intelligence, AI) is an important tool that physicians are using to treat complex heart arrhythmias. One of its principal advantages is that it helps to analyze patterns that are too complex and subtle for the human eye to identify. Conditions like atrial fibrillation (AF) are highly variable. The condition involves irregular electrical activity that changes with time and can be difficult to interpret consistently. While traditional diagnostic methods require heavy clinical interpretation (which might vary depending on experts), machine learning processes a large amount of electrocardiogram and imaging data to spot patterns with a level of consistency and precision that improves clinical decision-making (1).

Machine learning improves early detection and diagnosis. Many arrhythmias, like AF, can be asymptomatic or intermittent. The patient might not learn that they have a problem until they experience a complication such as a stroke. Also, machine learning algorithms can screen large datasets like wearable device data and electronic health records that can identify early warning signs. This makes it possible for clinicians to intervene early enough, reducing long-term risks and improving patient outcomes (2).

Further, machine learning also contributes to the treatment and mapping of arrhythmias (3). In procedures like catheter ablation, success might depend on accurately identifying the parts of the heart that are responsible for abnormal electrical signals. That process can be complex and inconsistent when it is done manually. Machine learning models like convolutional neural networks can classify electrical activation patterns with accuracy above 80%. This level of precision guides more targeted treatments, improving the possibility of long-term success.

Another advantage of machine learning is that it supports personalized treatment strategies (1-3). Often influenced by age, genetic disposition, and underlying conditions, patients have unique heart rhythm disorders. Machine learning can integrate several data sources to predict outcomes like recurrence after ablation. These models sometimes outperform traditional clinical risk scores, identifying additional risk factors while providing accurate predictions. This makes it easier for clinicians to tailor treatment and therapies more effectively to each individual patient.

Machine learning is improving efficiency and scalability across modern healthcare systems. Cardiologists work with large volumes of data from monitoring devices, imaging tools, and procedural mapping systems. Machine learning helps process this information quickly and accurately, highlighting the most relevant findings. This reduces the time spent on manual analysis and allows physicians to focus more on patient care while still benefiting from data-driven insights.

These tools also support better clinical decision-making. By identifying patterns that may not be immediately visible, machine learning helps clinicians detect arrhythmias earlier and assess them more precisely. This added level of insight can guide treatment planning and improve overall patient management. As a result, care becomes more proactive and tailored to individual patient needs.

At the same time, machine learning cannot replace clinical expertise (1). It works best as a support system that enhances the judgment of experienced physicians. Successful use depends on reliable data, clear algorithms, and thoughtful integration into everyday clinical practice. Collaboration between clinicians, engineers, and researchers remains essential to ensure that these tools deliver meaningful and accurate results.

Ultimately, machine learning brings clarity to complex arrhythmias. It strengthens detection, improves precision during treatment, and supports more personalized care. As the technology continues to evolve, it has the potential to reduce complications and improve long-term outcomes, shaping a more effective and patient-focused future in cardiac care.

(1) Armoundas, Narayan et al. “Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association” Circulation 2024 Vol. 149 Issue 14 Pages e1028-e1050
(2) Krittanawong, Narayan et al. “Deep learning for cardiovascular medicine: a practical primer” Eur Heart J 2019 Vol. 40 Issue 25 Pages 2058-2073
(3) Goldberger, Narayan et al. “Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future” Circ Arrhythm Electrophysiol 2024 Vol. 17 Issue 8 Pages e012939

About Sanjiv Narayan

Sanjiv Narayan is a professor of medicine at Stanford University who directs the atrial fibrillation program and electrophysiology research. With over 20 years of experience, he has held academic and clinical roles at institutions including UCLA, UC San Diego, Harvard Medical School, and Washington University. Educated at the University of Birmingham, he earned degrees in medicine, neuroscience, and software engineering. He is a Fellow of the American College of Cardiology and the Royal College of Physicians of London.

Share This Article